MFN2 and Alzheimer disease: Recently, in the senescence-accelerated mouse-prone 8 (SAMP8) line, a mouse model recapitulating the symptoms of late-onset sporadic AD, an age-dependent decrease in MFN2 expression in the hippocampus was found to be due to an increased expression of miR-19597.